Latest News

Press Release 3/09

Pioneers in Cardiac, Vascular and Interventional Technologies, Thomas Fogarty, MD, and Manny Villafana, to Present at InsynCVentures Start-Up Conference, April 22 in Dallas

read more


Luncheon Speaker Announced!

Manny Villafaña to Speak at insynCVentures Conference Luncheon "The Trials of the Entrepreneur Raising Capital"

read more


Press Release

InsynCVentures, a “Cardiovascular-Only” Strategic Partnering and Investment Conference, to be held on April 22 in Dallas

read more


Keynote Presentation

"Will the U.S. Maintain its Position as a World Leader in Medical Technology?" By Dr. Thomas Fogarty

read more


Panel Discussion

"CV Funding Strategies: Thinking Out of the Box"

read more


Contact Info

InsynCVentures
3943 Irvine Blvd., #150
Irvine, CA 92602

949.559.5511
send e-mail

 Sorry if you missed this exciting event.
Save the date for our upcoming med device investment and partnering event:

featuring presentations from 30+ early-stage orthopedics and spine companies

 November 10, 2009, The Grand Hyatt, San Francisco, 
prior to the NASS annual meeting

Also please visit our new home page, www.biomedgps.com!

 


Sharon O’Reilly and Michael Mack, MD
invite you to a one-day strategic partnering and investment
conference dedicated exclusively to Vascular Start-Ups

insynCVentures Conference: Where Cardiovascular Dealmakers and Emerging Companies Connect.

April 22, 2009

Westin Galleria Hotel • Dallas, Texas
Held Prior to the Dallas-Leipzig International Valve Congress 2009


Finally, a “cardiac and vascular only” conference designed specifically for you. Meet and interact with a select group of leading device manufacturers and investment firms specifically interested in keeping pace with innovations - and investing in - the high-growth segments of the cardio, neuro and peripheral vascular market.
 

Hear presentations from 30+ emerging companies focused solely on the interventional cardiology, cardiac surgery, neurointerventional and peripheral vascular markets—all seeking funding and strategic partnerships.  Take a look at our growing list of innovative Presenting Companies!

A Sampling of Attending Companies Sending their Senior Business Development Teams:
Medtronic, Cordis/J&J, Boston Scientific, Abbott Laboratories, Cook Group, Edwards Lifesciences, St. Jude Medical, CryoLife, Acorn Cardiovascular, Emergent Medical Partners, OrbusNeich Medical, Sorin Biomedica Cardio, SurModics, Longitude Capital, Emergence LLC, Sante Ventures, Versant Ventures, Orange Coast Medical Ventures, and Life Science Angels, among many others.
 

Hosts:

Sharon O'Reilly

Founder, former President & CEO of Medtech Insight,  
Originator of the “Investment In Innovation (In3)” conference series

Michael J. Mack, MD

Medical Director of Cardiovascular Surgery & Chairman of The Heart Hospital,
Baylor Plano Research Center,
Chairman, Cardiopulmonary Research Science Technology Institute (CRSTI)

 

Other Event Highlights:
  • Keynote Presentation by Dr. Thomas Fogarty, entitled "Will the U.S. Maintain its Position as a World Leader in Medical Technology?" – Dr. Fogarty is a renowned surgeon, inventor, entrepreneur, and successful winemaker. He is a professor of surgery at Stanford University and is president of Fogarty Engineering, one of the first medical device incubators from which many of his companies originate.
  • Luncheon Presentation by serial entrepreneur Manny Villafaña, entitled "The Trials of the Entrepreneur Raising Capital" - Mr. Villafaña is the founder of Cardiac Pacemakers, St. Jude Medical, GV Medical, ATS Medical, CABG Medical, and his newest venture, Kips Bay Medical.
  • Venture Capital/Business Development Panel Discussion entitled "CV Funding Strategies: Thinking Out of the Box" - designed to bring you up to date on the most relevant topics impacting today’s young vascular device companies
    Panelists:
      - Allan May, Managing Director, Emergent Medical Partners 
      - Jeff Gold, Venture Partner, Longitude Capital
      - Chad Cornell, Vice President, Corporate Development, Medtronic, Inc.
      - Monty Mars, Director, Corporate Development, Edwards Lifesciences 
  • Unlimited exhibit time during the entire conference
  • More breaks and time for networking

  

Where Cardiovascular Dealmakers and Emerging Companies Connect.